From: Chapter 41, Cost-effectiveness analyses
![Cover of Emergency and acute medical care in over 16s: service delivery and organisation](/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-niceng94-lrg.png)
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Risk factor and outcome (population) | Number of studies | Effect (95% CI) | Imprecision | GRADE Quality |
---|---|---|---|---|
Outlier versus non-outlier for predicting mortality (hospital mortality) (congestive heart failure and cardiac arrhythmia patients)a | 1 | Adjusted RR: 0.80 (0.40 to 1.60) | Seriousb | LOW |
Outlier versus non-outlier for predicting mortality (hospital mortality) (general medical patients)a | 1 | Adjusted RR: 1.41 (1.16 to 1.71) | No serious imprecision | MODERATE |
Outlier versus non-outlier for predicting mortality (hospital mortality) (medical and geriatric patients)a | 1 | Adjusted HR: 1.8 (1.28 to 2.53) | No serious imprecision | MODERATE |
Outlier versus non-outlier for predicting mortality (90 day mortality) (all admitted patients)a | 1 | RR: 0.75 (0.51 to 1.11) | Seriousb | VERY LOW |
Outlier versus non-outlier for predicting length of stay (days) (congestive heart failure and cardiac arrhythmia patients)a | 1 | Adjusted mean difference: 2.60 (0.60 to 4.60) | No serious imprecision | MODERATE |
Outlier versus non-outlier for predicting serious adverse events (infection) (congestive heart failure and cardiac arrhythmia patients)a | 1 | Adjusted RR: 1.50 (0.80 to 2.81) | Seriousb | LOW |
Outlier versus non-outlier for predicting serious adverse events (haemorrhage) (congestive heart failure and cardiac arrhythmia patients)a | 1 | Adjusted RR: 1.20 (0.40 to 3.60) | Seriousb | LOW |
Outlier versus non-outlier for predicting serious adverse events (transfer to ICU) (all admitted patients)a | 1 | RR: 1.05 (0.5 to 2.18) | Seriousb | VERY LOW |
Methods: multivariable analysis, including key covariates used in analysis to assess if outlier status is an independent risk factor. Key covariates included: age, case-mix, co-morbidities.
95% CI around the median crosses null line.
From: Chapter 41, Cost-effectiveness analyses
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.